_______________________________________________________________________________

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549


                                   __________

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


         Date of report (Date of earliest event reported) July 20, 1998.



                                   MEDJET INC.
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)



          Delaware                     000-11765               22-3283541
       (State or Other          (Commission File Number)    (I.R.S. Employer
Jurisdiction of Incorporation)                            Identification Number)


                     1090 King Georges Post Road, Suite 301
                            Edison, New Jersey 08837
          (Address of Principal Executive Offices, Including Zip Code)


                                 (732) 738-3990
              (Registrant's Telephone Number, Including Area Code)


                                 Not Applicable
          (Former Name or Former Address, if Changed Since Last Report)


_______________________________________________________________________________




ITEM 5.    OTHER EVENTS.

               Pursuant to an agreement with Patterson Travis, Inc., Medjet Inc.
          (the  "Registrant")  has extended the expiration date (the "Expiration
          Date") of its publicly traded Class A Redeemable Common Stock Warrants
          (the  "Warrants")  originally  issued  and sold by the  Registrant  in
          August  1996  in  connection  with  its  initial  public  offering  of
          securities  consisting of units,  each unit comprised of one (1) share
          of the  Registrant's  Common Stock, par value $.001 per share ("Common
          Stock"), and one (1) Warrant.

               Prior to the Expiration  Date,  which has been extended from 5:00
          p.m.  on  November  6, 1998 to 5:00 p.m.  on  November  6, 1999,  each
          Warrant entitles the holder thereof to purchase,  at an exercise price
          of $10 per share, one share of Common Stock.

               Certain  additional  information  regarding  the extension of the
          Expiration  Date is included in the press  release dated July 20, 1998
          (the "Press Release") which is filed as an exhibit hereto.

               The Press  Release is  qualified  in its entirety by reference to
          the complete text of such exhibit.


ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

         (c)   EXHIBITS.

               The following exhibits are filed with this Form 8-K:

                    4.1 Warrant Agreement, dated August 6, 1996, by and between
                    the  Registrant  and  Continental  Stock  Transfer  &  Trust
                    Company.

                    99.1  Press  Release   relating  to  the  extension  of  the
                    Expiration Date of the Warrants.







                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                   MEDJET INC.

                                   (REGISTRANT)



Date:  July 21, 1998            By:/s/ Terence A. Walts
                                   ---------------------------------------------
                                   Name:   Terence A. Walts
                                   Title:  President and Chief Operating Officer







                                  EXHIBIT INDEX

EXHIBIT NO.                    DESCRIPTION

4.1               Warrant  Agreement,  dated  August 6, 1996,  by  and   between
                  the   Registrant   and  Continental  Stock  Transfer  &  Trust
                  Company.


99.1             Press  Release  relating to the  extension  of  the  Expiration
                 Date of the  Warrants.